Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 9-MTH group results

Feb 13 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2024        Dec 31, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             29.28               29.73            45.50    
                 (-1.5 pct)          (-50.6 pct)      (+4.6 pct)  
  Operating       loss 1.47            336 mln            3.00    
                                     (-98.3 pct)      (-0.1 pct)  
  Recurring       loss 1.26            586 mln            3.00    
                                     (-97.0 pct)      (-11.9 pct) 
  Net             loss 1.38            154 mln            1.00    
                                     (-98.9 pct)      (-32.5 pct) 
  EPS          loss 11.45 yen         1.28 yen         8.30 yen   
  Ann Div                             17.00 yen        17.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             17.00 yen        17.00 yen  
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news